Medytox Inc., 10% Owner at Evolus, Inc. (EOLS), sold 4,375,022 shares at $8.50 ($37.2M) on 2023-02-07, disclosed to the SEC on 2023-02-08.
Open-market sale of $37.2M EOLS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.50 | 2,187,511 | $18.6M | 50.0% |
| 2 | $8.50 | 2,187,511 | $18.6M | 50.0% |
| Total | $8.50 avg | 4,375,022 | $37.2M | 100% |
| Filing → |
| EOLS | SELL | 2023-02-06 | $818K | — | Filing → |
| EOLS | SELL | 2022-10-07 | $689K | — | Filing → |
| EOLS | SELL | 2022-10-06 | $123K | — | Filing → |